Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Cheryl N. McMahill‐Walraven"'
Autor:
Rachel P. Ogilvie, J. Bradley Layton, Patricia C. Lloyd, Yixin Jiao, Djeneba Audrey Djibo, Hui Lee Wong, Joann F. Gruber, Ron Parambi, Jie Deng, Michael Miller, Jennifer Song, Lisa B. Weatherby, Lauren Peetluk, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Christine L. Bui, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, Grace Yang, Kandace L. Amend, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Mary S. Anthony, John D. Seeger, Azadeh Shoaibi
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study’s objective was to estimate the effectiveness of receiving a complete pr
Externí odkaz:
https://doaj.org/article/a71040a255aa47ef99a2668dec27e3e6
Autor:
J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, Patricia C. Lloyd, Joann F. Gruber, Michael Miller, Rachel P. Ogilvie, Jie Deng, Ron Parambi, Jennifer Song, Lisa B. Weatherby, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, John D. Seeger, Grace Wenya Yang, Dóra Illei, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi
Publikováno v:
Vaccine: X, Vol 16, Iss , Pp 100447- (2024)
Background: Monovalent booster/additional doses of COVID-19 vaccines were first authorized in August 2021 in the United States. We evaluated the real-world effectiveness of receipt of a monovalent booster/additional dose of COVID-19 vaccine compared
Externí odkaz:
https://doaj.org/article/24a425573ed6479eb8e9ad2ca557699a
Autor:
Rita Hamad, Kristin A. Lyman, Feng Lin, Madelaine F. Modrow, Pelin Ozluk, Kristen M. J. Azar, Amie Goodin, Carmen R. Isasi, Heather E. Kitzman, Sara J. Knight, Gregory M. Marcus, Cheryl N. McMahill-Walraven, Paul Meissner, Vinit Nair, Emily C. O’Brien, Jeffrey E. Olgin, Noah D. Peyser, Gosia Sylwestrzak, Natasha Williams, Mark J. Pletcher, Thomas Carton
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background It is increasingly recognized that policies have played a role in both alleviating and exacerbating the health and economic consequences of the COVID-19 pandemic. There has been limited systematic evaluation of variation in U.S. l
Externí odkaz:
https://doaj.org/article/90ca3f0c57444e63bbb7defdc676bbae
Autor:
Mayura Shinde, Carla Rodriguez-Watson, Tancy C. Zhang, David S. Carrell, Aaron B. Mendelsohn, Young Hee Nam, Amanda Carruth, Kenneth R. Petronis, Cheryl N. McMahill-Walraven, Aziza Jamal-Allial, Vinit Nair, Pamala A. Pawloski, Anne Hickman, Mark T. Brown, Jennie Francis, Ken Hornbuckle, Jeffrey S. Brown, Jingping Mo
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Currently available medications for chronic osteoarthritis pain are only moderately effective, and their use is limited in many patients because of serious adverse effects and contraindications. The primary surgical option for ost
Externí odkaz:
https://doaj.org/article/df37bcff230042b385fbdc6c48e7d378
Autor:
Eric Jutkowitz, Julie P.W. Bynum, Susan L. Mitchell, Noelle M. Cocoros, Oren Shapira, Kevin Haynes, Vinit P. Nair, Cheryl N. McMahill‐Walraven, Richard Platt, Ellen P. McCarthy
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the p
Externí odkaz:
https://doaj.org/article/1548c96c22824f1caa0c0657b7815845
Autor:
Pamela M McMahon, Ann Chen Wu, Emily Welch, Cheryl N McMahill-Walraven, Aziza Jamal-Allial, Mia Gallagher, Tancy Zhang, Christine Draper, Anne Marie Kline, Leslie Koerner, Jeffrey S Brown, Melissa K Van Dyke
Publikováno v:
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
Background In the USA, over 25 million people have asthma; 5%–10% of cases are severe. Mepolizumab (Nucala) is an interleukin-5 antagonist monoclonal antibody; it was approved by the FDA in 2015 as add-on maintenance treatment of severe asthma for
Externí odkaz:
https://doaj.org/article/a4000989c82e44b89309f6032c91585b
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
Autor:
Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, Kandace Amend, Daniel C. Beachler, Cheryl N. McMahill-Walraven, Elizabeth R. Smith, John Seeger, Alex Secora, Djeneba Audrey Djibo, Joyce Obidi, Yuhui Feng, Jennifer Song, Christian Reich, Charalynn Harris, Sandia Akhtar, Robin Clifford, Nandini Selvam, Jennifer L. Pigoga, Yixin Jiao, Yoganand Chillarige, Thomas MaCurdy, Richard Forshee, Steven A. Anderson
Publikováno v:
Vaccine. 40:6481-6488
Active monitoring of safety outcomes following COVID-19 vaccination is critical to understand vaccine safety and can provide early detection of rare outcomes not identified in pre-licensure trials. We present findings from an early warning rapid surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f45f224befa1e313aefa58c7c9a7ec
https://doi.org/10.1016/j.vaccine.2022.09.060
https://doi.org/10.1016/j.vaccine.2022.09.060
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D. Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
Publikováno v:
JAMA Pediatrics.
ImportanceActive monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials.ObjectiveTo conduct near–real-time monitoring of health outcomes following BNT162b2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c7500b602b68fab78767c74766d3be
https://doi.org/10.1001/jamapediatrics.2023.1440
https://doi.org/10.1001/jamapediatrics.2023.1440
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
ImportanceActive monitoring of health outcomes following COVID-19 vaccination offers early detection of rare outcomes that may not be identified in pre-licensure trials.ObjectiveTo conduct near-real time monitoring of health outcomes following BNT162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66234f2d329803a45b6a6553863e73ea
https://doi.org/10.1101/2022.10.28.22281532
https://doi.org/10.1101/2022.10.28.22281532
Autor:
Dena M. Carbonari, Judith C. Maro, Adee Kennedy, Jolene Damon, Gaia Pocobelli, Vincent Lo Re, Lauren E. Parlett, Michael D. Nguyen, Charles E. Leonard, David J. Graham, Jerry Jacob, Vinit P. Nair, Esther H. Zhou, Jennifer G. Lyons, Mano S. Selvan, Yunping Zhou, Nicole Haug, William R. Short, Cheryl N. McMahill-Walraven
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:899-909
Purpose Identifying hospitalizations for serious infections among patients dispensed biologic therapies within healthcare databases is important for post-marketing surveillance of these drugs. We determined the positive predictive value (PPV) of an I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be667295a8a16383b4987c1db4b141d2
https://doi.org/10.1002/pds.5253
https://doi.org/10.1002/pds.5253